(Total Views: 73)
Posted On: 11/13/2023 12:30:48 PM
Post# of 15407

$MBRX News Article - Penny Stock Moleculin Highlights Interim Data From Blood Cancer Study With Complete Response Rate of 38% | Benzinga https://marketwirenews.com/news-releases/penn...54813.html


My Twitter: WhyteStocks